News & Events
June 16, 2016 - Roche and Phoebus Genetics Offer Patients Access to Microarray-Based Non-Invasive Prenatal Testing
May 2, 2016 - In-network status for non-invasive prenatal test now includes four largest national private health plans and Medi-Cal
New publication shows consistent clinical performance in screening common fetal trisomies with Harmony Prenatal Test
Nov. 3, 2015 – Roche and Ariosa Diagnostics, a global leader in non-invasive prenatal testing technology and maker of the Harmony™ Prenatal Test, today announced the results of a new clinical study on the company’s targeted cell-free DNA analysis using microarray quantitation which...
Oct. 13, 2015 - Roche and Ariosa Diagnostics, in conjunction with Australian company Sonic Healthcare, today announced that Sonic Healthcare has been granted a license to perform the Harmony Prenatal Test in its Australian and United Kingdom labs.
June 11, 2015 – Roche (SIX: RO, ROG; OTCQX:RHHBY). First wave of laboratories in Europe will conduct Harmony Prenatal Test in their own labs
June 11, 2015 – Roche (SIX: RO, ROG; OTCQX:RHHBY) Ariosa Diagnostics, Inc., a global leader in non-invasive prenatal testing (NIPT), today announced its proprietary FORTE™ software has received the CE mark (Conformité Européenne).